MediPal Holdings Corporation (TYO:7459)

Market Cap	496.79B
Revenue (ttm)	3.65T
Net Income (ttm)	49.43B
Shares Out	207.95M
EPS (ttm)	236.48
PE Ratio	10.10
Forward PE	13.66
Dividend	60.00 (2.48%)
Ex-Dividend Date	Mar 28, 2025

Volume	469,100
Average Volume	402,205
Open	2,410.50
Previous Close	2,387.00
Day's Range	2,371.50 - 2,412.50
52-Week Range	2,185.50 - 2,770.00
Beta	0.00
RSI	63.37
Earnings Date	May 13, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In 2023, MediPal Holdings's revenue was 3.56 trillion, an increase of 5.91% compared to the previous year's 3.36 trillion. Earnings were 41.47 billion, an increase of 6.88%.